218 related articles for article (PubMed ID: 10719957)
1. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
[TBL] [Abstract][Full Text] [Related]
2. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
3. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
Martinez V; Christensen D; Kayser V
Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
[TBL] [Abstract][Full Text] [Related]
4. Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
Christensen D; Gautron M; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):433-440. PubMed ID: 10568851
[TBL] [Abstract][Full Text] [Related]
5. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
[TBL] [Abstract][Full Text] [Related]
6. Tolerance to morphine analgesia: evidence for stimulus intensity as a key factor and complete reversal by a glycine site-specific NMDA antagonist.
Adam F; Bonnet F; Le Bars D
Neuropharmacology; 2006 Aug; 51(2):191-202. PubMed ID: 16713606
[TBL] [Abstract][Full Text] [Related]
7. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
[TBL] [Abstract][Full Text] [Related]
8. The glycine site-specific NMDA antagonist (+)-HA966 enhances the effect of morphine and reverses morphine tolerance via a spinal mechanism.
Adam F; Dufour E; Le Bars D
Neuropharmacology; 2008 Mar; 54(3):588-96. PubMed ID: 18177675
[TBL] [Abstract][Full Text] [Related]
9. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery.
Christensen D; Kayser V
Pain; 2000 Dec; 88(3):231-238. PubMed ID: 11068110
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats.
Eisenach JC; Gebhart GF
Anesthesiology; 1995 Nov; 83(5):1046-54. PubMed ID: 7486155
[TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
12. Magnesium increases morphine analgesic effect in different experimental models of pain.
Begon S; Pickering G; Eschalier A; Dubray C
Anesthesiology; 2002 Mar; 96(3):627-32. PubMed ID: 11873038
[TBL] [Abstract][Full Text] [Related]
13. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
14. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
15. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C.
Mao J; Price DD; Mayer DJ
J Neurosci; 1994 Apr; 14(4):2301-12. PubMed ID: 7908958
[TBL] [Abstract][Full Text] [Related]
16. GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice.
Quartaroli M; Fasdelli N; Bettelini L; Maraia G; Corsi M
Eur J Pharmacol; 2001 Nov; 430(2-3):219-27. PubMed ID: 11711034
[TBL] [Abstract][Full Text] [Related]
17. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy.
Mao J; Price DD; Hayes RL; Lu J; Mayer DJ
Brain Res; 1992 Dec; 598(1-2):271-8. PubMed ID: 1362520
[TBL] [Abstract][Full Text] [Related]
18. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen enriched saline alleviates morphine tolerance via inhibiting neuroinflammation, GLT-1, GS nitration and NMDA receptor trafficking and functioning in the spinal cord of rats.
Li Q; Zhang H; Jia Z; Zhang L; Li Y; Xu R; Wang C; Yu Y
Neurosci Lett; 2021 Jun; 755():135847. PubMed ID: 33774150
[TBL] [Abstract][Full Text] [Related]
20. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]